NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 380 / 982

  1. Determination of the enantiomeric composition of amphetamine, methamphetamine and 3,4‐methylendioxy‐N‐methylamphetamine (MDMA) in seized street drug samples from southern Germany2021 · OpenAlex
  2. Determination of the naturally occurring vanadium-complex amavadin in Amanita muscaria with HPLC-ICPMS2021 · Crossref
  3. Determination the cut-off point for the Bergen social media addiction (BSMAS): Diagnostic contribution of the six criteria of the components model of addiction for social media disorder2021 · OpenAlex
  4. Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review2021 · OpenAlex
  5. Determining the nutritional value and quality indicators of meat-containing bread made with hemp seeds flour (Cannabis sativa L.)2021 · Crossref
  6. Detrimental Impact of Digitalization on Pupils’ Personality Traits and Physiological Development2021 · Crossref
  7. Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis2021 · OpenAlex
  8. Developing a strategy for designing light in drug addiction centers2021 · Crossref
  9. Developing an Adaptive Mobile Intervention to Address Risky Substance Use Among Adolescents and Emerging Adults: Usability Study2021 · OpenAlex
  10. Developing and Testing Molecular Markers in Cannabis sativa (Hemp) for Their Use in Variety and Dioecy Assessments2021 · Crossref
  11. Developing and testing of an interactive internet-based intervention to reduce sexual harm of sexualised drug use (‘chemsex’) among men who have sex with men in Hong Kong: a study protocol for a randomised controlled trial2021 · OpenAlex
  12. Developing and validating a measurement tool to self-report perceived barriers in substance use treatment: the substance use treatment barriers questionnaire (SUTBQ)2021 · Crossref
  13. Development and Evaluation of a Digital Health Intervention for Substance Use Reduction in Young Refugees With Problematic Use of Alcohol and/or Cannabis—Study Protocol for a Single-Armed Feasibility Trial2021 · Crossref
  14. Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.2021 · PubMed
  15. Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone2021 · Crossref
  16. Development and initial validation of the nonalcoholic fatty liver disease self‐management questionnaire2021 · Crossref
  17. Development and Optimization of Nefopam hydrochloride Push-Pull Osmotic Pumps by Design of Experiments2021 · Crossref
  18. Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol2021 · OpenAlex
  19. Development and Psychometric Properties of the Synthetic Drug Dependence Scale in a Chinese Sample2021 · OpenAlex
  20. Development and testing of relative risk-based health messages for electronic cigarette products2021 · Crossref
  21. Development and Translation of NanoBEO, a Nanotechnology-Based Delivery System of Bergamot Essential Oil Deprived of Furocumarins, in the Control of Agitation in Severe Dementia2021 · OpenAlex
  22. Development and validation of a rapid LC‐MS/MS method for the detection of 182 novel psychoactive substances in whole blood2021 · OpenAlex
  23. Development and validation of a rapid liquid chromatography/tandem mass spectrometry method to quantitate gabapentin and buprenorphine in human serum2021 · Crossref
  24. Development and validation of a real-time PCR assay to detect Cannabis sativa in food2021 · Crossref
  25. Development and Validation of an Instrument to Measure Parental Factors Related to Substance Use Prevention in Adolescents2021 · Crossref
  26. Development and Validation of News Addiction Scale2021 · Crossref
  27. Development and validation of patient-community pharmacist encounter toolkit regarding substance misuse: Delphi procedure2021 · OpenAlex
  28. Development and validation of the Maudsley Modified Patient Health Questionnaire (MM-PHQ-9)2021 · OpenAlex
  29. Development and Validation of the Smartphone Addiction Scale for Children- Parent Version (SASC-P)2021 · Crossref
  30. Development of a New LC-MS/MS Screening Method for Detection of 120 NPS and 43 Drugs in Blood2021 · OpenAlex
  31. Development of a Novel Microwave Distillation Technique for the Isolation of Cannabis sativa L. Essential Oil and Gas Chromatography Analyses for the Comprehensive Characterization of Terpenes and Terpenoids, Including Their Enantio-Distribution2021 · OpenAlex
  32. Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans2021 · Crossref
  33. Development of an analytical method for detection of Imidacloprid Insecticide from Biological Matrix using LC-MS/MS2021 · Crossref
  34. Development of an inverse low‐temperature plasma ionization source for liquid chromatography/mass spectrometry2021 · Crossref
  35. Development of an MRI-Compatible Nasal Drug Delivery Method for Probing Nicotine Addiction Dynamics2021 · Crossref
  36. Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities2021 · Crossref
  37. Development of HPLC Method for Catechins and Related Compounds Determination and Standardization in Miang (Traditional Lanna Fermented Tea Leaf in Northern Thailand)2021 · Crossref
  38. Development of Surface Coating based Hybrid Acrylic Copolymers for Coating Application, Preparation, Characterization and Processing2021 · Crossref
  39. Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD2021 · Crossref
  40. Development Over Time of the Population-Attributable Risk Fraction for Cannabis Use Disorder in Schizophrenia in Denmark2021 · OpenAlex
  41. Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice2021 · OpenAlex
  42. Developmental exposure to MDMA (ecstasy) in zebrafish embryos reproduces the neurotoxicity adverse outcome ‘lower motor activity’ described in humans2021 · OpenAlex
  43. Developmental Trajectories of Cannabis and Alcohol Use Among a Longitudinal Sample of Secondary School Students in Ontario2021 · Crossref
  44. Dexamethasone Does not Compensate for Local Anesthetic Cytotoxic Effects on Tenocytes: Morphine or Morphine Plus Dexamethasone May Be a Safe Alternative2021 · Crossref
  45. Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis2021 · OpenAlex
  46. DFT-D4 Insight into the Inclusion of Amphetamine and Methamphetamine in Cucurbit[7]uril: Energetic, Structural and Biosensing Properties2021 · OpenAlex
  47. Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction2021 · OpenAlex
  48. Diagnosis of cognitive function changes in patients with abdominal neoplasms occurring in the early postsurgery period and management of those with neuroprotective drug2021 · Crossref
  49. Dialectical behaviour therapy skills training for individuals with substance use disorder: A systematic review2021 · Crossref
  50. Did the 2018 Farm Bill’s Hemp Provisions Decriminalize Marijuana?2021 · Crossref
  51. Dietary and Nutritional Strategy for the Prevention and Management of Hyperuricemia2021 · Crossref
  52. Dietary Consumption Among Youth with Antipsychotic-Induced Weight Gain and Changes Following Healthy Lifestyle Education2021 · Crossref
  53. DIFERENCIAS DE ALTERACIONES PSICOMOTRICES ENTRE EL USO DE COCAÍNA Y DE COCAÍNA-HEROÍNA EN UNA SALA DE VENOPUNCIÓN2021 · OpenAlex
  54. Difference in Harvesting Time for The Chemical Quality of Red Betel Leaf (Piper crocatum Ruiz & Pav.)2021 · Crossref
  55. Differences between cancer patients and others who use medicinal Cannabis2021 · Crossref
  56. Differences in Personality and Family Environment of Heroin Addicts And Non-consumers of Psychoactive Substances2021 · Crossref
  57. Differences in problem alcohol drinking by military service type among male professional military personnel in South Korea using Military Health Survey data2021 · Crossref
  58. Differences in Quit Attempts, Successful Quits, Methods, and Motivations in a Longitudinal Cohort of Adult Tobacco Users by Sexual Orientation2021 · Crossref
  59. Different Cannabis sativa Extraction Methods Result in Different Biological Activities against a Colon Cancer Cell Line and Healthy Colon Cells2021 · Crossref
  60. Different drugs come with different motives: Examining motives for substance use among people who engage in polysubstance use undergoing methadone maintenance therapy (MMT)2021 · OpenAlex
  61. Differential dopamine release by psychosis-generating and non-psychosis-generating addictive substances in the nucleus accumbens and dorsomedial striatum2021 · OpenAlex
  62. Differential Effects of State Policy Environments on Substance Use by Sexual Identity: Findings From the 2000–2015 National Alcohol Surveys2021 · Crossref
  63. Differential impacts of ridesharing on alcohol-related crashes by socioeconomic municipalities: rate of technology adoption matters2021 · Crossref
  64. Differential importance of nucleus accumbens Ox1Rs and AMPARs for female and male mouse binge alcohol drinking2021 · Crossref
  65. Differential regulation of STP, LTP and LTD by structurally diverse NMDA receptor subunit-specific positive allosteric modulators2021 · OpenAlex
  66. Differential Reversal of the Ventilatory‐Depressant Effects of Fentanyl and its Derivatives by Naloxone in Monkeys2021 · Crossref
  67. Differential Serotonin Uptake Mechanisms at the Human Maternal–Fetal Interface2021 · OpenAlex
  68. Differential Treatment Effects of Methylphenidate and Atomoxetine on Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder2021 · Crossref
  69. Differentiation of Mitragyna speciosa, a narcotic plant, from allied Mitragyna species using DNA barcoding-high-resolution melting (Bar-HRM) analysis2021 · OpenAlex
  70. Difficulties in Potato Pest Control: The Case of Pyrethroids on Colorado Potato Beetle2021 · Crossref
  71. Difficulties of general practitioners in (de)prescribing benzodiazepines2021 · Crossref
  72. Digested Civet Coffee Beans (Kopi Luwak)—An Unfortunate Trend in Specialty Coffee Caused by Mislabeling of Coffea liberica?2021 · Crossref
  73. Digital Addiction of Employees: Damages to Quality of Life in Organizations?2021 · Crossref
  74. Digital Addiction: Systematic Review of Computer Game Addiction Impact on Adolescent Physical Health2021 · OpenAlex
  75. Digital localisation in an illicit market space: interactional creation of a psychedelic assemblage in a darknet community of exchange2021 · OpenAlex
  76. Dimensions of Craving Interact with COMT Genotype to Predict Relapse in Individuals with Alcohol Use Disorder Six Months after Treatment2021 · Crossref
  77. DIMENSIONS OF CRIME INVOLVING WOMEN IN DRUG TRAFFICKING - LITERATURE REVIEW FROM DEPENDENT BEHAVIOR TO RELAPSE2021 · Crossref
  78. Dioecious hemp (Cannabis sativa L.) plants do not express significant sexually dimorphic morphology in the seedling stage2021 · Crossref
  79. Discharge from the trauma centre: exposure to opioids, unmet information needs and lack of follow up—a qualitative study among physical trauma survivors2021 · OpenAlex
  80. Disciplinary Approaches for Cannabis Use Policy Violations in Canadian Secondary Schools2021 · Crossref
  81. Disclosures of harming others during their most recent drinking session: Findings from a large national study of heavy‐drinking adolescents2021 · Crossref
  82. Discordance Between Perinatal Alcohol Use Among Women and Provider Counseling for Alcohol Use: An Assessment of the Pregnancy Risk Assessment Monitoring System2021 · Crossref
  83. Discounting, Cognitive Inflexibility, and Antisocial Traits as Predictors of Adolescent Drug Involvement2021 · Crossref
  84. Discovery and Genetic Mapping of PM1, a Powdery Mildew Resistance Gene in Cannabis sativa L.2021 · Crossref
  85. Discovery research and development history of the dopamine D2 receptor partial agonists, aripiprazole and brexpiprazole2021 · OpenAlex
  86. Disentangling craving‐ and valence‐related brain responses to smoking cues in individuals with nicotine use disorder2021 · OpenAlex
  87. Disentangling substance use and related problems: urgency predicts substance-related problems beyond the degree of use2021 · Crossref
  88. Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature2021 · OpenAlex
  89. Dismantling Racism Against Black, Indigenous, and People of Color across the Substance use Continuum: A Position Statement of the Association for Multidisciplinary Education and Research in Substance use and Addiction2021 · Crossref
  90. Disparities in Opioid Overdose Death Trends by Race/Ethnicity, 2018–2019, From the HEALing Communities Study2021 · OpenAlex
  91. Disparities in risk perception and low harm reduction services awareness, access, and utilization among young people with newly reported hepatitis C infections in California, 20182021 · Crossref
  92. Disparities in Social and Economic Determinants of Health by Sexual Identity, Gender, and Age: Results from the 2015–2018 National Survey on Drug Use and Health2021 · Crossref
  93. Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis2021 · OpenAlex
  94. Disputes over the permissibility of tobacco smoking among the ulama of Ottoman Syria2021 · Crossref
  95. Disrupted H2S Signaling by Cigarette Smoking and Alcohol Drinking: Evidence from Cellular, Animal, and Clinical Studies2021 · Crossref
  96. Disrupting the medial prefrontal cortex with designer receptors exclusively activated by designer drug alters hippocampal sharp‐wave ripples and their associated cognitive processes2021 · Crossref
  97. Disrupting the α7nAChR–NR2A protein complex exerts antidepressant-like effects2021 · OpenAlex
  98. Disruption to Substance and Opioid Use Disorder: The Deep South Substance and Opioid Use Rural Training Grant2021 · Crossref
  99. Dissemination of Cognitive Behavioral Therapy for Substance Use Disorders in the Department of Veterans Affairs Health Care System: Description and Evaluation of Veteran Outcomes2021 · Crossref
  100. Dissociative identity (multiple personality) disorder in Poland: a clinical case description and diagnostic difficulties2021 · OpenAlex